We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Cadmium Promotes Cancer by Inhibiting DNA Repair

By Biotechdaily staff writers
Posted on 23 Jun 2003
Researchers have found that cadmium promotes the development of cancer by inhibiting the ability of cells to repair routine errors made when the DNA is copied to make new cells. More...


Cadmium is a naturally occurring element, found in all soils and rocks, including coal and fertilizers. It is used in metal coatings and plastics and batteries, partly because it does not corrode easily. People are exposed to cadmium from breathing cigarette smoke, drinking contaminated water, or eating foods that contain it.

Investigators at the National Institute of Environmental Health Sciences (NIEHS, Research Triangle Park, NC, USA) working with a yeast model found that cadmium reduced the capacity for post-replication mismatch repair (MMR) of small misalignments and base-base mismatches. In extracts of human cells, cadmium inhibited at least one step leading to mismatch removal. Inactivation of DNA repair mechanisms causes hypermutability, a condition that encourages uncontrolled cell growth. These findings were published June 8, 2003, in the online edition of Nature Genetics.

Senior author Dr. Dmitry A. Gordenin, a NIEHS researcher, explained, "Unless cadmium is unique in its mechanism, it would seem that environmental factors may cause genetic defects and cancer not only by attacking our DNA directly but also by undermining the mechanisms by which faulty DNA replication is repaired.”





Related Links:
The National Institute of Environmental Health Sciences

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.